Core A: Administrative and Biostatistics Core
Core A: Administrative and Biostatistics Core
批准号:
10245066
负责人:
CARL H. JUNE
金额:
$15.12万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-15 至 2023-07-31
关键词:
AchievementAddressAnnual ReportsBasic ScienceBiometryBiostatistics CoreBudgetsCAR T cell therapyCancer CenterCellular immunotherapyClinicalClinical TrialsCommunicationDataDiseaseDoctor of PhilosophyEnsureGenesGenetic EngineeringGoalsHematologic NeoplasmsHuman ResourcesInfrastructureLeadershipLearningMonitorOperations ResearchPennsylvaniaPhysician ExecutivesProgress ReportsPublishingReportingResearchResearch PersonnelRoleSafetyScheduleScientistServicesStructureT cell therapyTestingTimeLineUniversitiesUpdateauthoritychimeric antigen receptor T cellsclinical research siteclinical trial implementationdata sharingdesigninnovationmedical schoolsmeetingsnoveloperationorganizational structurepharmacovigilancepreservationprogramsresponsesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY CORE A: ADMINISTRATIVE AND BIOSTATISTICS
The Administrative Core (Core A) will provide clinical and scientific leadership, effective communication and
fiscal and bio-statistical support to ensure the success of all Program Project activities. This proposal
seeks to build upon our track record in genetically engineered T cell therapy by enhancing the chimeric antigen
receptor T cell platform to specifically address systemic vulnerabilities that we have observed in our clinical
trials to date. Our overarching hypothesis is that novel gene editing approaches can remove the remaining
obstacles in the path of universally-available and universally-active CAR T cell therapy for hematologic
malignancy. We have brought together a cadre of exceptional investigators who have collaborated and
published together for many years. Each disease-focused project will be led by a recognized authority in the
field. The three cores that support this proposal have been critical to the success of our clinical CAR T cell
program to date and their expertise will underpin the success of this proposal. The centerpiece of each project
is an innovative clinical trial that seeks to test our major hypotheses. We are leveraging the proven
translational infrastructure, administrative staff and the centralized research organizations at the Center for
Cellular Immunotherapies at the Perelman School of Medicine to achieve our objectives. Strong institutional
commitment from the Abramson Cancer Center, Perelman School of Medicine and the University of
Pennsylvania have facilitated our scientific and translational achievements. The essential services
provided by Core A include: administrative support for all of the investigators in each project and core; fiscal
management and oversight for all components of the Program Project; and organization and communication of
all Program Project meetings and activities. The overall goal of this Core is effective and efficient leadership of
the P01. The roles of the Director, Co-investigators and administrative staff are to facilitate communication and
organizational structure while stimulating scientific and technological interactions. In order to achieve this goal,
the Core has established four objectives: (1) To oversee the safety and monitoring activities for Penn
and CHOP clinical sites; (2) To provide statistical support for clinical trials, projects and cores and implement
plans to promote data sharing; (3) To coordinate the interactions among clinicians and scientists in projects
and cores, internal and external advisory boards, and NCI personnel regarding effective implementation of
proposed objective; (4) To provide budgetary services such as tracking expenses and providing investigator's
monthly reports.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering the Next Generation of T Cells
-
批准号:10578324
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2019
-
负责人:CARL H. JUNE
-
依托单位:
Engineering the next generation of T cells
-
批准号:10064451
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2019
-
负责人:CARL H. JUNE
-
依托单位:
Directing the metabolic fate of CAR T cells
-
批准号:10364746
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2018
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
-
批准号:10713199
-
项目类别:
-
资助金额:$278.23万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Project 2: Towards a safe and effective AML treatment strategy using anti-CD33 CAR T cells in combination with CAR-resistant hematopoietic stem cells
-
批准号:10245064
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Project 2: Towards a safe and effective AML treatment strategy using anti-CD33 CAR T cells in combination with CAR-resistant hematopoietic stem cells
-
批准号:9982244
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
-
批准号:9280418
-
项目类别:
-
资助金额:$289.74万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
-
批准号:9982239
-
项目类别:
-
资助金额:$170.2万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Core A: Administrative and Biostatistics Core
-
批准号:9982247
-
项目类别:
-
资助金额:$11.2万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
-
批准号:10245062
-
项目类别:
-
资助金额:$219.44万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Core A: Administrative and Clinical Translational Core
-
批准号:10713203
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8601689
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
Role of co-receptor modified cells in HIV infection
-
批准号:8889623
-
项目类别:
-
资助金额:$156.67万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8989883
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
Role of co-receptor modified cells in HIV infection
-
批准号:8469110
-
项目类别:
-
资助金额:$128.7万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
Role of co-receptor modified cells in HIV infection
-
批准号:8519303
-
项目类别:
-
资助金额:$131.48万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8243893
-
项目类别:
-
资助金额:$51.14万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8442843
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
FACSAria II Cell Sorter for Non-Biohazardous Cells
-
批准号:7793915
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:CARL H. JUNE
-
依托单位:
Core E: Molecular Gene Delivery/Modification Core
-
批准号:8066106
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2010
-
负责人:CARL H. JUNE
-
依托单位:
海外基金